Articles From: Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation to iShares Interest Rate Hedged High Yield Bond ETF (HYGH) and iShares Asia/Pacific Dividend ETF (DVYA) to Participate in NYSE ARCA ETP Incentive Program


Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the initiation of a Phase III clinical trial in the U.S. evaluating a 72 mcg capsule of linaclotide to be taken once per day for the treatment of adults suffering from chronic idiopathic constipation (CIC). Linaclotide is currently approved by the U.S. Food and Drug Administration as a 145 mcg capsule to be taken once per day for the treatment of adults with CIC and as a 290 mcg capsule to be taken once per day for the treatment of adults with irritable bowel syndrome with constipation (IBS-C). “The 72 mcg dose of linaclotide may provide physicians with more options that may enable them to better serve their adult chronic idiopathic constipation patients,” said Dr.
Sign-up for Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation investment picks
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today provided an update on its third quarter 2014 and recent business activities.
Sign-up for Ironwood Pharmaceuticals Provides Third Quarter 2014 Investor Update investment picks
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Credit Suisse 2014 Healthcare Conference on Tuesday, November 11, 2014 at 3:00 p.m. Mountain Time / 5:00 p.m. Eastern Time at the Arizona Biltmore in Phoenix.
Sign-up for Ironwood Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference investment picks
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 33 rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time at the Westin St.
Sign-up for Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference investment picks
2014/11/11
BUENOS AIRES, Argentina , Nov.
Sign-up for IRSA Inversiones y Representaciones S.A. Announces Results for the First Three Months 2015 Ended September, 2014 investment picks
2015/1/14
By David Weidner, MarketWatch Wells Fargo's results, after all, show that big banks can still increase profits SAN FRANCISCO (MarketWatch) -- If you want to know the key difference in today's post-financial-crisis banking, look no further than the latest results from J.P. Morgan Chase & Co.
Sign-up for Is 'management' the real problem at J.P. Morgan? investment picks
2011/01/27
Investors have lost more than $160 billion in structured and complex income investments, says John Wasik.
Sign-up for Is a Structured Product Good for Retirement Income? investment picks
By Tomi Kilgore, MarketWatch Continued listing fees are a lot lower on Nasdaq than on NYSE The iconic Gordon Gekko character in the movie "Wall Street" said: "It is all about bucks, child.
Sign-up for Is AMD's move to Nasdaq from NYSE really about efficiency and natural fit? investment picks
2012/08/19
Readers weigh issues of money, accessibility, and proximity to friends and family when deciding whether to move to a smaller home.
Sign-up for Is Downsizing Part of Your Retirement Plan? investment picks
2014/12/4
By Jennifer Booton, MarketWatch IBM shares have underperformed the market for 3 straight years NEW YORK (MarketWatch)--IBM Corp.
Sign-up for Is IBM ripe for activist intervention? investment picks
2014/10/23
By Therese Poletti, MarketWatch SAN FRANCISCO (MarketWatch) -- The pressure on IBM Corp.
Sign-up for Is IBM's Rometty up to the hard work ahead? investment picks
2011/03/20
Readers opine about rising premiums and the pros and cons of self-insuring.
Sign-up for Is Long-Term Care Insurance Right for You? investment picks
2015/01/20
Some funds that invest in other funds charge additional fees, and here's how you can tell.
Sign-up for Is My Target-Date Fund Layering On Extra Fees? investment picks
2015/1/20
By Ophir Gottlieb Getting subscribers hasn't been a problem so far, but expansion plans are costing a lot of money Netflix's stock is up 240% during the past two years.
Sign-up for Is Netflix stuck in earnings stagnation? investment picks
2015/01/21
As retailers have fallen under pressure to start the year, we look at retail ETFs for investors who see a buying opportunity.
Sign-up for Is Retail in Retreat? investment picks
2015/1/6
By Andria Cheng, MarketWatch NEW YORK (MarketWatch) -- Coach Inc. has decided one way to spur growth and turn its fortunes around is by making its first acquisition.
Sign-up for Is shoe brand Stuart Weitzman the right fit for Coach? investment picks
2014/11/27
By Charles Passy, MarketWatch Retailers trumpet their family-friendly policies For many retailers, the decision to remain closed on Thanksgiving is rooted in the idea of honoring the all-American holiday and letting employees enjoy time off with friends and family.
Sign-up for Is staying closed on Thanksgiving a sly marketing move? investment picks
2008/11/06
This vehicle can lessen the impact of tax increases.
Sign-up for Is the Roth 401(k) Right for You? investment picks
2014/11/25
By Barbara Kollmeyer, MarketWatch Critical intelligence before the U.S. market opens Yesterday, this column talked about how a less-optimistic outlook on stocks might be a good thing for investors next year.
Sign-up for Is the S&P's future healthy after all, and a 'Broken Friday' for retailers investment picks
2015/01/11
Research suggests certain personality traits can influence a range of investment decisions and outcomes.
Sign-up for Is Your Personality Impacting Your Portfolio? investment picks
2011/05/12
The essential first step for retirement portfolio planning: finding the right stock/bond mix.
Sign-up for Is Your Retirement Portfolio's Asset Allocation on Track? investment picks
2011/10/18
The essential first step for retirement portfolio planning: finding the right stock/bond mix.
Sign-up for Is Your Retirement Portfolio's Asset Allocation on Track? investment picks
2011/02/16
The essential first step for retirement portfolio planning: finding the right stock/bond mix.
Sign-up for Is Your Retirement Portfolio's Asset Allocation on Track? investment picks
2011/03/18
An estate-planning expert shares insights on who needs to take action--and who doesn't.
Sign-up for Is Your Wealth Safe Under New Estate Tax Laws? investment picks
SAN DIEGO, CA , Nov.
Sign-up for Isaac Capital Group Closes $5 Million Preferred Stock Deal with Dataram Corporation investment picks
Results of industry benchmark study to be presented at IAOP 2015 Outsourcing World Summit STAMFORD, Conn.
Sign-up for ISG and IAOP Announce Launch of 2015 State of the Industry Survey investment picks
4Q ACV up 27 percent from prior year; contract volume up 6 percent 2014 ACV up 16 percent, to $23.1 billion, fueled by growth in ITO, new scope and restructured contracts, mega-relationships Americas and Asia Pacific deliver strong double-digit ACV growth for the year; EMEA up 7 percent STAMFORD, Conn.
Sign-up for ISG Index: Strong 4Q Caps One of Best Years Ever for Outsourcing investment picks
ISG joins top IT leaders to discuss how Technology Business Management (TBM) can be used to maximize the value of IT investments STAMFORD, Conn.
Sign-up for ISG to Sponsor, Present at TBM Conference in Miami investment picks
ISG Momentum® Report Finds Contract Counts Rising More than Total Spending Across Service Lines as Clients Split Scope and Engage Multiple Service Providers STAMFORD, Conn.
Sign-up for ISG: Demand for Specialists Pushes Outsourcing Volume Higher investment picks
As of January 2, 2015, iShares Interest Rate Hedged High Yield Bond ETF (HYGH), an active ETF and iShares Asia/Pacific Dividend ETF (DVYA) will begin participating in the NYSE Arca ETP Program on its listing market, NYSE Arca.
Sign-up for iShares Interest Rate Hedged High Yield Bond ETF (HYGH) and iShares Asia/Pacific Dividend ETF (DVYA) to Participate in NYSE ARCA ETP Incentive Program investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation to iShares Interest Rate Hedged High Yield Bond ETF (HYGH) and iShares Asia/Pacific Dividend ETF (DVYA) to Participate in NYSE ARCA ETP Incentive Program
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent